Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...

Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” but because its scope fundamentally changes how organizations must recruit, ...

Trust is often a major barrier to companies integrating AI tools. Learn how better data governance can improve confidence.

Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...

GenAide, founded in 2016, acts as an end-to-end export partner, manages 65 fully approved products, and serves over 35 ...

The EU Health Data Space raises hopes for research and industry. Although there is still a long way to go, further data spaces have been announced.

AWS also introduced the Trainium 3 chip and new AI-optimised servers designed to handle resource-intensive healthcare workloads such as genomics pipelines, biomarker discovery, molecular-simulation ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

ICON’s June 2025 survey of more than 100 investigators and site leaders reveals persistent bottlenecks in study startup ...

Clinical research is one of the most dynamic and rapidly growing areas within the pharma and biotech industry. As new ...

Nabla, one of the most widely adopted AI assistants in clinical care, has been selected by LCMC Health to power a systemwide rollout of its advanced ambient AI technology across the New Orleans?based ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.